Podcasts about singal

-Trump's gestapo kidnaps another student over her pro-Palestine views -Singal chat messages reveal evidence of a war crime, prove top officials lied -RFK Jr. is shutting down Long Covid research -Boeing set to receive a bailout with new military boondoggle

VOICI LE GRAND RETOUR DES....DUO D'ENCORE✨Quelle joie de retrouver au micro Edith et Clémentine, deux femmes, amies dans la vie et amoureuses du vivant, du vibrant.Dans ce format que j'affectionne tant – celui des voix qui se croisent, des silences qui laissent place à la confidence – naît quelque chose de rare : l'intime partagé. Une conversation sans âge, où l'on s'écoute avec le cœur grand ouvert.Dans cet épisode, vous découvrirez l'histoire d'une amitié intergénérationnelle comme on en écoute peu : complice, vive, rayonnante.Vous entendrez les éclats de rire, le souffle d'un vent de bonheur, les frémissements d'un débat sincère.Vous croiserez deux battantes, deux militantes, deux âmes qui n'ont jamais cessé de croire à un monde meilleur – et d'agir pour le rendre réel.Elles se retrouvent sur bien des terrains : la solidarité, l'engagement, la transmission, la tendresse, le courage.Bonne écouteEt surtout, partagez cette dose de joie à un maximum de monde ✨Pour suivre le podcast, c'est par ici sur Instagram.Nous avons parlé également de:l'association Singal'organisme où se sont rencontrées Edith et Clémentine: Institut des futurs souhaitablesHébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

  On this episode Razib talks to Jesse Singal, a journalist who has covered the social science beat for the last decade. Singal has an undergraduate degree in philosophy from University of Michigan and a master's in public affairs from Princeton. Currently a freelance journalist who writes his own Substack, Singal-Minded, and contributes to Blocked and Reported with Katie Herzog, Singal is formerly an editor at New York Magazine. His first book The Quick Fix: Why Fad Psychology Can't Cure Our Social Ills, covered the replication crisis. Razib and Singal first talk about what he learned, and unlearned, during his time as a reporter at New York Magazine, especially social psychology results that were long on glamor but short on robustness. They discuss how long we've known that social psychology had a problem, and whether it still hasn't reformed itself. Singal also reflects on his role in publicizing sexy findings, and how journalism has taken steps to be more careful lately. They also address some of the specific findings that came out of early 2010's social science, from implicit bias to power posing. Next, Razib asks Singal about youth gender medicine, and the major controversies over the last few years. Singal discusses the differences between female to male transitions as opposed to male to female, and relates the whole domain back to the replication crisis and the lack of good research. They also discuss political and social aspects, and where Singal sees youth gender medicine going in the next few years.

Interview with Anik Singal In this podcast interview on Power Your Profits, Anik Singal, a successful entrepreneur and CEO of Lurn Inc., shares his story of resilience and transformation after a difficult 18-month investigation by the Federal Trade Commission (FTC). Despite building a $40 million company with a strong reputation, Singal was hit with a $2.5 million FTC settlement that cost him an estimated $15 million in total losses, including a pending acquisition. He reflects on how the experience, which was even more mentally and emotionally draining than a life-threatening health crisis, has shaped his new mission of helping entrepreneurs navigate compliance and avoid legal pitfalls. Singal now focuses on educating others about FTC regulations, offering valuable lessons learned from his experience while rebuilding his business. His message is one of service, resilience, and the importance of understanding legal compliance in entrepreneurship. Connect with Anik Singal: Website: https://aniksingal.com/ Facebook:⁠ https://www.facebook.com/AnikSingalcom/ Instagram: https://www.instagram.com/anik/ YouTube: https://www.youtube.com/channel/UCinyEr-Fly9Yp1zMFx_D0cQ Connect with Susie: Visit Susie's Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://susiecarder.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Listen To The Podcast: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/POWERYOURPROFITS⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Fractional COO Services: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.coo.poweryourprofitspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ The Bullet Train to Big Profits Course: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.course.poweryourprofitspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Buy The Power Your Profits Book: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://book.poweryourprofitspodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.Launch Date: November 26, 2024Release Date: November 26, 2024Expiration Date: October 31, 2025FACULTYAshwani K. Singal, MD, MS, FACG, FAASLD, AGAFProfessor of Medicine, University of LouisvilleTransplant Hepatologist and Staff PhysicianTraeger Transplant Center and Jewish HospitalDirector Clinical Trials, University of LouisvilleThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-from-aasld-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis-17

Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.Launch Date: November 26, 2024Release Date: November 26, 2024Expiration Date: October 31, 2025FACULTYAshwani K. Singal, MD, MS, FACG, FAASLD, AGAFProfessor of Medicine, University of LouisvilleTransplant Hepatologist and Staff PhysicianTraeger Transplant Center and Jewish HospitalDirector Clinical Trials, University of LouisvilleThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/clinical-clips174-from-aasld-2024-key-breakthroughs-in-the-treatment-of-primary-biliary-cholangitis-17

It's estimated that this year, on average, 76 Canadian men will be diagnosed with prostate cancer every day. In Canada, prostate cancer makes up 22% of all cancer diagnoses in men. However unlike many cancers, prostate cancer is a condition that you can live and even thrive with. Here, Dr. Peter Nord and Dr. Rajiv Singal hear from two Medcan clients who were diagnosed and treated for prostate cancer here at Medcan. Hear about their experiences, how you can prevent prostate cancer, and why a diagnosis does not have to hold you back from living a long and happy life.  LINKS Visit our Men's Health webpage to learn more about your prostate cancer risk and stay up to date on your screening. See more prostate cancer statistics from the Canadian Cancer Society Read some of the latest research on prostate cancer prevention and management: ”...higher intake of plant foods after prostate cancer diagnosis was associated with lower risk of cancer progression,” from this 2024 study in JAMA Network Open KEY MOMENTS 00:57 How common is prostate cancer? 03:44 Your risk goes up with age 4:58 It might not affect your quality of life at all 6:54 Men don't always advocate for their health 7:55 Meet two Medcan clients who were diagnosed with prostate cancer 9:19 What is PSA? 11:59 Prostate cancer screening: MRI, PSA ratio and biopsy 14:08 Experience and risk of getting a biopsy 16:22 The Gleason Score, and stages of prostate cancer 20:50 Is it cancer or BPH? (benign prostatic hyperplasia) How to know 23:47 Does testosterone increase your risk of prostate cancer? 25:02 Your PSA trend matters more than your current levels 26:24 A regular GP may not have caught this Medcan client's cancer 27:55 Treatment options: radiation vs surgery 30:55 The importance of being proactive about your health and recovery  31:34 One man's post-surgery 10,000 step streak 34:36 Surgery results and recovery 36:52 Lifestyle choices that can prevent an enlarged prostate 37:36 Tips from two of Dr. Singal's patients  

El nos dice su experiencia y el tiempo que tubo en el albergue con su hijo que solo tenia meses de nacido. El nos habla de su experiencia en el systema y como salio de eso. El es un padre soltero son un hijo de 10 anos. EL dice que tiene que tener una mente positiva. Email or DM us to share your story: ⁠⁠⁠⁠⁠⁠NYCHearOurVoices@gmail.com ⁠⁠⁠⁠⁠⁠ Hear Our Voices on ⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠ account links can be found on ⁠⁠⁠⁠⁠⁠Linktr.ee/nyc_hov⁠⁠⁠⁠⁠

On this episode of Liver Talks, Alex and Adam are joined by Amit Singal, HCC expert and Chief of Hepatology at UT Southwestern, for a fascinating conversation about the latest and greatest in HCC. Then, a new segment is born featuring Rob Wilechansky, a transplant hepatology fellow at MGH and Hepatology's editorial fellow, in which they discuss an exciting new article from a recent issue of the journal. AASLD HCC Guideline: https://journals.lww.com/hep/fulltext/9900/aasld_practice_guidance_on_prevention,_diagnosis,.441.aspx Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study: https://pubmed.ncbi.nlm.nih.gov/37162151/ Hosts Adam Winters @adam_c_winters Alex Vogel @AlexSVogel Guests: Amit Singal @docamitgs Robert Wilechansky @WilechanskyMD Edited by: Taylor Gouterman Music Credits: “Tropkicks”, Broke for Free “Something Elated”, Broke for Free “Take Me Higher”, Jahzzar “RSPN,” Blank & Kytt All music furnished by https://freemusicarchive.org/ under Creative Commons licensing. http://brokeforfree.com/ https://jahzzar.bandcamp.com/ https://blankkytt.bandcamp.com/

Amit Singal, MD, MS - Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted Therapies in Advanced HCC

Amit Singal, MD, MS - Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted Therapies in Advanced HCC

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers trauma and addictions with Dr. Gabor Maté, a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver's Downtown East Side with patients challenged by drug addiction and mental illness. The bestselling author of five books published in thirty languages, including the award-winning In the Realm of Hungry Ghosts: Close Encounters with Addiction, Dr. Maté is an internationally renowned speaker highly sought after for his expertise on addiction, trauma, childhood development, and the relationship of stress and illness. For his groundbreaking medical work and writing he has been awarded the Order of Canada, his country's highest civilian distinction, and the Civic Merit Award from his hometown, Vancouver. His fifth book, The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture was released on September 13, 2022.   The learning objectives for this episode are as follows:   By the end of this episode, you should be able to… Understand the connection between trauma and the development of addictions and other mental illnesses Critically reflect on current diagnostic and treatment paradigms Apply principles of trauma-informed care to psychiatric assessment and the provision of mental health services   Guest: Dr Gabor Maté   Hosts: Sena Gok, Rhys Linthorst, Angad Singh, Nikhita Singhal, and Alex Raben   Audio editing by: Sena Gok   Show notes by: Nikhita Singhal   Interview Content: Introduction - 0:00 Learning objectives - 01:43 Defining trauma - 02:14 Current dominant views of addiction - 07:27 Defining addiction - 11:05 Relationship between trauma and addiction - 16:15 Neurobiology of addiction - 17:20 Brain development - 25:48 Genetic susceptibility - 36:10 Trauma-informed approach to treatment - 39:45 Importance of therapeutic relationships - 44:10 Societal barriers - 48:15 Harm reduction - 54:32 Closing comments - 01:00:14   Resources: Books: In the Realm of Hungry Ghosts (Gabor Maté) The Myth of Normal (Gabor Maté) The Body Keeps The Score (Bessel van der Kolk) The Archaeology of Mind: Neuroevolutionary Origins of Human Emotions (Jaak Pansepp, Lucy Biven) Dr Gabor Maté's website: https://www.drgabormate.com Adverse Childhood Experiences (ACEs) study: https://doi.org/10.1016/s0749-3797(98)00017-8 More information on ACEs from Harvard University's Center on the Developing Child: What Are ACEs? And How Do They Relate to Toxic Stress? Compassionate Inquiry (psychotherapeutic approach developed by Dr Gabor Maté)   References: Brown, T., Berman, S., McDaniel, K., Radford, C., Mehta, P., Potter, J., & Hirsh, D. A. (2021). Trauma-Informed Medical Education (TIME): Advancing Curricular Content and Educational Context. Academic medicine: journal of the Association of American Medical Colleges, 96(5), 661–667. https://doi.org/10.1097/ACM.0000000000003587 Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2014. (Treatment Improvement Protocol (TIP) Series, No. 57.) Chapter 3, Understanding the Impact of Trauma. Available from: https://www.ncbi.nlm.nih.gov/books/NBK207191/ Colon-Rivera Hector, A., Aoun, E. & Vaezazizi, L. M. (2023). Addiction Psychiatric Medicine: A Comprehensive Board Review. Elsevier. Dugosh, K.L. & Cacciola J. (2022). Clinical assessment of substance use disorders. In J. A. Melin (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/clinical-assessment-of-substance-use-disorders Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. American journal of preventive medicine, 14(4), 245–258. https://doi.org/10.1016/s0749-3797(98)00017-8 Fundamentals of Addiction: Screening. CAMH. Retrieved from  https://www.camh.ca/en/professionals/treating-conditions-and-disorders/fundamentals-of-addiction/f-of-addiction---screening Michaels, T. I., Stone, E., Singal, S., Novakovic, V., Barkin, R. L., & Barkin, S. (2021). Brain reward circuitry: The overlapping neurobiology of trauma and substance use disorders. World journal of psychiatry, 11(6), 222–231. https://doi.org/10.5498/wjp.v11.i6.222 Olsen Y. (2022). What Is Addiction? History, Terminology, and Core Concepts. The medical clinics of North America, 106(1), 1–12. https://doi.org/10.1016/j.mcna.2021.08.001 Panksepp J. (2011). The basic emotional circuits of mammalian brains: do animals have affective lives? Neuroscience and biobehavioral reviews, 35(9), 1791–1804. https://doi.org/10.1016/j.neubiorev.2011.08.003 Powers, A., Petri, J. M., Sleep, C., Mekawi, Y., Lathan, E. C., Shebuski, K., Bradley, B., & Fani, N. (2022). Distinguishing PTSD, complex PTSD, and borderline personality disorder using exploratory structural equation modeling in a trauma-exposed urban sample. Journal of anxiety disorders, 88, 102558. https://doi.org/10.1016/j.janxdis.2022.102558 Shonkoff, J. P., Richter, L., van der Gaag, J., & Bhutta, Z. A. (2012). An integrated scientific framework for child survival and early childhood development. Pediatrics, 129(2), e460–e472. https://doi.org/10.1542/peds.2011-0366 Volkow, N. D., & Li, T. K. (2004). Drug addiction: the neurobiology of behaviour gone awry. Nature reviews. Neuroscience, 5(12), 963–970. https://doi.org/10.1038/nrn1539   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.   For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.  

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.07.13.548931v1?rss=1 Authors: Hobson, R., Levy, S. H. S., Flaherty, D., Xiao, H., Ciener, B., Reddy, H., Singal, C., Teich, A. F., Shneider, N. A., Bradshaw, E. M., Elyaman, W. Abstract: Recent murine studies have highlighted a crucial role for the meninges in surveilling the central nervous system (CNS) and influencing CNS inflammation. However, how meningeal immunity is altered in human neurodegeneration and its potential effects on neuroinflammation is understudied. In the present study, we performed single-cell analysis of the transcriptomes and T cell receptor repertoire of 72,576 immune cells from 36 postmortem human brain and leptomeninges tissues from donors with neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimers disease, and Parkinsons disease. We identified the meninges as an important site of antigen presentation and CD8 T cell activation and clonal expansion and found that T cell activation in the meninges is a requirement for infiltration into the CNS. We further found that natural killer cells have the potential to negatively regulate T cell activation locally in the meninges through direct killing and are one of many regulatory mechanisms that work to control excessive neuroinflammation. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

For our celebratory 100th episode, podcasting role-models Katie Herzog and Jesse Singal join the Dorx as special guest audio engineers. Except Corinna's been so busy testifying for “anti-trans" bills around the country, and Nina's been so sick with COVID, that we only made it to episode 98. Nonetheless, we cover gender wars, egregious reporting, backlashes, Drag Queen story hours, Trump Derangement Syndrome, the Minority Stress Model, men in women's sports, persecution complexes, Twitter, Substack, pizzas, Katie's goddess-like spouse, Nina's “butch energy,” safety pins, and pronouns, learning that in spite of a few irreconcilable differences, all agree that “they” is a terrible choice for individuals. Links: Katie & Jesse's podcast: https://www.blockedandreported.org/ Riley Gaines at San Francisco State University: https://www.thefire.org/news/protestors-chased-down-riley-gaines-after-her-campus-speech-sfsu-says-its-proud-events Posie Parker in New Zealand: https://www.feministcurrent.com/2023/03/25/kellie-jay-keen-is-attacked-and-mobbed-by-trans-activists-in-new-zealand/ Nina's GiveSendGo: https://www.givesendgo.com/apocalypseanimated --- Support this podcast: https://podcasters.spotify.com/pod/show/heterodorx/support

Order my first book 'Build, Don't Talk' here: https://amzn.eu/d/eCfijRu--------------In today's episode of Figuring Out, Raj is in conversation with IPS Ravinder Singal, the Additional Director General of Police. Apart from his public servant profile, he's also an Endurance athlete and the only bureaucrat to have finished the Ironman Triathlon at the age of 50! IPS Singal is known to have managed the Kumbh Mela of 2003 by himself and has also served as the Chief of the War Crimes Investigation Unit at United Nations Mission, Kosovo and also handled various national missions. He's also a motivational speaker & a writer and is actively associated with the Cyber Crime Awareness programmes in the country. IPS shares with us his experience of serving the country and sheds light on the current crime scene of India. He expresses his concerns over the movies ruining the image of Indian Police and gives a directive on how couples can be more aware in order to not fall prey to crimes related to live-in relationships.  To learn more about how India deals with crime, Law & order, watch the video till the end! -------------------------

My main and WhatsApp number is 8512045374 !!!

This is a free preview of a paid episode. To hear more, visit wethefifth.substack.com* Apocalypse apparel* No country for fat men* Singal white journalist * A left-wing Matt *Walsh* stan * Books don't make a man* Kancel Kmele Pls* On Mistaken Misgendering* Dippin toes, stepping on rakes* A message from Julia (TBC)* Moynihan engineers a Fifth Marriage* The zaps of SSRI withdrawl…* Burning down the house - followed by  * A listener wonders: were my Italian grandpa…

An exclusive club indeed Download the Callin app for iOS and Android to listen to this podcast live, call in, and more! Also available at callin.com

Singal talked about diversity training and fad psychology with the guys.

In this episode, Phillip Lanos and Jason Miller are joined by Vikas Singal, Founder, and CEO of SamBlogs.com. Vikas Singalhave has been doing digital Marketing since 2010. They have recently got an award for the fastest-growing digital marketing agency in Jaipur, India.Tune in to learn more!For more go to: https://www.strategicadvisorboard.comConnect:Strategic Advisor Board: www.linkedin.com/company/strategic-advisor-boardJason Miller: www.linkedin.com/in/jasontmiller-sabPhillip Lanos: www.linkedin.com/in/philliplanosVikas SingalLinkedIn: https://www.linkedin.com/in/TheVikasSingal/website: https://samblogs.com/

Analyzing The 2022 Elections And Predicting 2024. Steve Williamson, Karen McClelland and Stephen Hanks welcome our favorite political prognosticator, Dan Singal, back to the show to discuss the midterm elections. As it turned out, his predictions were proven amazingly accurate. … Continue reading →

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

Go online to PeerView.com/QYD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. As the choice of regimens for patients with hepatocellular carcinoma (HCC) continues to expand with new standard-of-care therapies for advanced disease, and emerging innovative locoregional and multimodal strategies for early- and intermediate-stage disease, clinicians who treat liver cancer have increased opportunities to collaborate with colleagues and improve patient outcomes. Designed to guide professionals into a new era of team-based personalized care, this Seminars & Tumor Board activity features a multidisciplinary panel of experts who will link current science and treatment recommendations to practical guidance on therapeutic decision-making. Using case-based discussion, the expert panel will address a variety of clinical issues such as treatment selection, sequencing, and the integration of systemic therapy with locoregional management. It takes a team to provide the best care for your patients—participate in this activity to hear the latest on using collaborative strategies to optimize outcomes in HCC. Upon completion of this activity, participants should be better able to: Evaluate the efficacy/safety profiles and clinical roles of novel and emerging systemic therapy approaches for patients with advanced/metastatic HCC; Review the latest evidence on innovative strategies, including novel locoregional modalities, combinations of locoregional and systemic therapies, and perioperative/conversion approaches, for patients with HCC across the disease continuum; Develop contemporary, personalized management plans for patients with HCC that consider the available clinical evidence, expert/guideline recommendations, clinical trial opportunities, and patient-, disease-, and treatment-specific factors; and Implement best practices for multidisciplinary collaboration and care coordination when managing patients with HCC, including team-based strategies to maximize treatment efficacy, safety, tolerability, and patient quality of life.

The Second Radio Synchrotron Background Workshop: Conference Summary and Report by J. Singal et al. on Wednesday 30 November We summarize the second radio synchrotron background workshop, which took place June 15-17, 2022 in Barolo, Italy. This meeting was convened because available measurements of the diffuse radio zero level continue to suggest that it is several times higher than can be attributed to known Galactic and extragalactic sources and processes, rendering it the least well understood electromagnetic background at present and a major outstanding question in astrophysics. The workshop agreed on the next priorities for investigations of this phenomenon, which include searching for evidence of the Radio Sunyaev-Zeldovich effect, carrying out cross-correlation analyses of radio emission with other tracers, and supporting the completion of the 310 MHz absolutely calibrated sky map project. arXiv: http://arxiv.org/abs/http://arxiv.org/abs/2211.16547v1

Á streymisveitunni Spotify er að finna EP-plötuna Reif í dæluna með listamanninum Atlantsolía , sem sagt olíufyrirtækinu og bensínstöðinni. Þessi fjögurra laga plata frá árinu 2021 inniheldur lögin Bið ekki um meira, Bensínhetjuna, Bensínlaus og Dælur víða. Það er Saga Garðarsdóttir, leikkona og grínisti, sem syngur og semur textana og Helgi Sæmundur Guðmundsson úr hljómsveitinni Úlfur Úlfur sem semur tónlistina. Um miðjan október birtist frétt á vef fréttablaðsins með fyrirsögninni 'Olíufélag fær gullplötu fyrir pirrandi heilaorma,' en það var plötuútgáfan Alda Music sem veitti Atlantsolíu gullplötu, í tilefni þess að lögin af plötunni Reif í dæluna eru komin með yfir 60 þúsund spilanir á Spotify. Við skoðum íslenska tónlist sem er samin fyrir auglýsingar, en ná stundum vinsældum. Nú eru tæpar tvær vikur í heimsmeistaramótið í knattspyrnu karla hefjist í Katar og margir með hugan við boltann. Meðal annars Viktoría Blöndal, skáld og sviðshöfundur, sem hefur spilað fótbolta frá barnsaldri og verið að skoða þessa vinsælu íþrótt. Hún mun flytja innslög í Lestinni næstu þriðjudaga í nóvember um fótboltann sem er elskaður og hataður en aldrei hunsaður. Kvikmyndaskóli Íslands fagnar 30 ára afmæli í mánuðinum. Að því tilefni fengum við að rölta um skólann með Berki Gunnarssyni sem hefur gegnt embætti rektors undanfarna mánuði frá því að Friðrik Þór Friðriksson hætti. Við kíktum niður á Suðurlandsbraut 18 í húsnæði kvikmyndaskólans.

Á streymisveitunni Spotify er að finna EP-plötuna Reif í dæluna með listamanninum Atlantsolía , sem sagt olíufyrirtækinu og bensínstöðinni. Þessi fjögurra laga plata frá árinu 2021 inniheldur lögin Bið ekki um meira, Bensínhetjuna, Bensínlaus og Dælur víða. Það er Saga Garðarsdóttir, leikkona og grínisti, sem syngur og semur textana og Helgi Sæmundur Guðmundsson úr hljómsveitinni Úlfur Úlfur sem semur tónlistina. Um miðjan október birtist frétt á vef fréttablaðsins með fyrirsögninni 'Olíufélag fær gullplötu fyrir pirrandi heilaorma,' en það var plötuútgáfan Alda Music sem veitti Atlantsolíu gullplötu, í tilefni þess að lögin af plötunni Reif í dæluna eru komin með yfir 60 þúsund spilanir á Spotify. Við skoðum íslenska tónlist sem er samin fyrir auglýsingar, en ná stundum vinsældum. Nú eru tæpar tvær vikur í heimsmeistaramótið í knattspyrnu karla hefjist í Katar og margir með hugan við boltann. Meðal annars Viktoría Blöndal, skáld og sviðshöfundur, sem hefur spilað fótbolta frá barnsaldri og verið að skoða þessa vinsælu íþrótt. Hún mun flytja innslög í Lestinni næstu þriðjudaga í nóvember um fótboltann sem er elskaður og hataður en aldrei hunsaður. Kvikmyndaskóli Íslands fagnar 30 ára afmæli í mánuðinum. Að því tilefni fengum við að rölta um skólann með Berki Gunnarssyni sem hefur gegnt embætti rektors undanfarna mánuði frá því að Friðrik Þór Friðriksson hætti. Við kíktum niður á Suðurlandsbraut 18 í húsnæði kvikmyndaskólans.

Vikas Singal, a profound Indian Entrepreneur, a professional SEO Expert and Digital Marketing Strategist who has been working in the Digital Marketing Industry for over 11+ Years. He is always busy, but proficient in managing multiple projects, prioritizing and meeting tight deadlines, analyzing and solving problems in accelerated, high-pressure environments. He is well known for providing invaluable service to all of his clients, helping them accelerate the growth of their business, regardless of the size. Whether their company is a small business, start-up, challenger brand or enterprise, Vikas and his team make growing the business a priority. 

In this HCI Podcast episode, Dr. Jonathan H. Westover talks with Vikas Singal about overcoming failures, learning from setbacks, and leveraging technology to add value to the market. Vikas Singal (https://www.linkedin.com/in/thevikassingal/) is an experienced Professional SEO Consultant and Founder of Grownle.com and Samblogs.com. He has been bringing growth, ingenuity, and experience into the SEO World for the last 11+ Years. He is well known for helping various eminent brands and startups, working in competitive SEO industries in different niches and languages all over the world. He also has a vast experience in fighting challenges that he has been using to help his clients succeed. Please consider supporting the podcast on Patreon and leaving a review wherever you listen to your podcasts! Check out Ka'Chava at www.Kachava.com/HCI. Check out BELAY here. Check out BetterHelp at www.BetterHelp.com/HCI to explore plans and options! Check out the HCI Academy: Courses, Micro-Credentials, and Certificates to Upskill and Reskill for the Future of Work! Check out the LinkedIn Alchemizing Human Capital Newsletter. Check out Dr. Westover's book, The Future Leader. Check out Dr. Westover's book, 'Bluer than Indigo' Leadership. Check out Dr. Westover's book, The Alchemy of Truly Remarkable Leadership. Check out the latest issue of the Human Capital Leadership magazine. Each HCI Podcast episode (Program, ID No. 592296) has been approved for 0.50 HR (General) recertification credit hours toward aPHR™, aPHRi™, PHR®, PHRca®, SPHR®, GPHR®, PHRi™ and SPHRi™ recertification through HR Certification Institute® (HRCI®). Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode features Dr. Shruti Singal, Chief Medical Officer at First Choice Health. Here, she discusses what motivated her to transition from practicing emergency room physician to leadership, her focus on access to care, the importance of being lifelong learner, and more.

Optimism For Democrats In Upcoming Elections. Steve Williamson and Karen McClelland welcome historian Dan Singal back to the show to give his views on the current state of politic affairs. Asked about Democrats' prospects for the midterms, Singal, who has … Continue reading →

We discuss the border, battleground state races, and more. Our Guests Are: Kris Kobach, Joe Kent, Sherrona Bishop, Elizabeth Nader, Frank Gaffney, Boris Epshteyn, Oscar RamirezStay ahead of the censors - Join us warroom.org/joinAired On: 7/25/2022Watch:On the Web: http://www.warroom.orgOn Gettr: @WarRoomOn Podcast: http://warroom.ctcin.bioOn TV: PlutoTV Channel 240, Dish Channel 219, Roku, Apple TV, FireTV or on https://AmericasVoice.news. #news #politics #realnews

Hey everyone and welcome back to Eggs. This week we have special guest, SEO wizard, and entrepreneur, Vikas Singal. Also known as Sam, Vikas is the creator of SamBlogs a digital marketing firm based in India. Unlike your typical SEO agency, SamBlogs creates a unique experience for their clients that addresses their challenges and caters to their business needs with clarity, simplicity, experience, and most importantly honesty. From a small village in India, and with a background in mechanical engineering, Vikas has long been entrepreneurial. In 2008, he started his first marketing agency in Mumbai but unfortunately — or fortunately — it failed. It was a devastating blow, but also became one of the most profound learning experiences in his life. Just a few years later Vikas discovered digital marketing and realized he'd found his calling. Working independently at first, then rapidly growing, he discovered he had a unique understanding of SEO — or search engine optimization. He developed his knowledge and in short order launched SamBlogs, which has become one of the top digital marketing agencies in India. It's been a wild ride, and we can't wait to dig in. Joining us today for a conversation about the importance of blogging in a company's SEO strategy, things that any business can do to improve their SEO today, how to know where your business stands currently from an SEO perspective, and so much more. Please join us in welcoming to the show Vikas Singal.Our Guest:Vikas SingalSEO Expert and Founder at SamsBlogsOfficial website: https://samblogs.com/ ----Credits:Hosted by Michael Smith and Ryan RoghaarTheme music: "Perfect Day" by OPMThe Carton:https://medium.com/the-carton-by-eggsThe Eggs Podcast Spotify playlist:bit.ly/eggstunesThe Plugs:The Showeggscast.com@eggshow on twitter and instagramOn iTunes: itun.es/i6dX3pCOn Stitcher: bit.ly/eggs_on_stitcherAlso available on Google Play Music!Mike "DJ Ontic" shows and infodjontic.com@djontic on twitterRyan Roghaarhttp://rogha.ar

Piney is joined by kiwi weightlifter Megan Signal who finally gets to compete at a games after missing both the 2018 Gold Coast Commonwealth games and Tokyo 2020 Olympics due to injury.LISTEN ABOVE

Writer M.K. Anderson joins me to discuss her recent Protean article on writer Jesse Singal, who has made a career out of "just asking questions" about trans issues. We discuss the article's analysis, how Singal's transphobic work is deployed by right-wing activists and legislators against trans people, and how Singal reacts to criticism. Plus, your calls. Download the Callin app for iOS and Android to listen to this podcast live, call in, and more! Also available at callin.com

Vineet Singal, co-founder and CEO of CareMessage, a messaging platform for health safety net organizations, joins Dominique and David to share why he created CareMessage out of his original work in San Francisco's Tenderloin neighborhood. He talks about why he turned down a scholarship to medical school to continue this work, and why he is so passionate about helping underserved populations manage their conditions and take responsibility for their health. Vineet describes how CareMessage grew from a Stanford undergraduate project to become the largest patient engagement program in the United States and discusses the types of data held by CareMessage and other healthcare clinics, as well how as how they ensure their HIPAA compliance. Vineet also explores how the COVID-19 pandemic has been a critical component of CareMessage's growth in ways he could not have anticipated when he started the company in 2012.

Making Sense Of Presidential Elections. Steve and Karen welcome back author and historian, Dan Singal, to discuss Critical Election Theory. If you are unfamiliar with the theory, it holds that, approximately every 36 years, a political realignment occurs in which … Continue reading →

The History Of Trump's Paranoid Style Of Politics. Friend of the show, author Dan Singal, joins Steve Williamson and Karen McClelland to discuss the rural/urban divide and how Trumpism came about. He explains the phenomenon by referencing Richard Hofstadter, perhaps … Continue reading →

Shruti Singal MD is Vice President of Medical Management and First Choice Health, a next-generation third-party administrator, offering employers a forward-thinking alternative to traditional health insurance.

It's common to see tech journalists make proclamations about how the internet has fundamentally changed the ways that we think, interact, and most importantly, argue with one another. It's also common to see them herald the arrival of a “new science” that promises to provide technical answers to all questions and solve all problems that come with the “disruptive” technologies that have “revolutionized” our world.But has the internet really caused such a drastic divergence from how we operate offline? And do we really need a “new science” for studying things like argument and disagreement, especially when already-established disciplines like rhetoric, philosophy, and the conspicuously named argumentation theory have been studying these topics for millenia?On today's episode, we offer a re:joinder to an infamous 2019 article in The Atlantic by Jesse Singal, entitled “The New Science of How to Argue--Constructively.” In the article, Singal profiles a man who claims to have invented a “new science of disagreement” - the Swedish blogger John Nerst, a self-proclaimed polymath who cut his teeth in the “Intellectual Dark Web”-adjacent, hyper-rationalist online blogosphere. Nerst's “new discipline,” which he calls “Erisology,” claims to have invented a series of tools to help people better navigate arguments and disagreements online. In reality, as we point out, Nerst has merely stumbled into concepts and theories that have been debated by theorists of logic and argumentation for centuries, such as stasis theory, ideographs, and “bracketing” social difference in public deliberations. The distinction, we find, is that Nerst's and Singal's vision of a new culture of disagreement is reliant on rationalist rules that belie an authoritarian social and political agenda. We also discuss how privileged men react when their ideas are challenged for the first time, Jesse Singal's beleaguered Twitter mentions, and what this article truly reveals about the nature of the internet: its power to elevate bloggers to the status of credentialed, peer-reviewed academics, as long as their ideas are laundered through online op-ed columnists.In the spirit of generosity, here is Nerst's follow-up blog explaining & defending his ideas: “A Defense of Erisology”Works and Concepts Cited in this Episode:re:blurb on Stasis Theoryre:blurb on IdeographsFahnestock, J., & Secor, M. (1988). The stases in scientific and literary argument. Written communication, 5(4), 427-443.Fraser, N. (1990). Rethinking the public sphere: A contribution to the critique of actually existing democracy. Social text, (25/26), 56-80.Habermas, J. (1991). The structural transformation of the public sphere: An inquiry into a category of bourgeois society. MIT press.Hohmann, H. (2001). Stasis. In T. O. Sloane (Ed.), Encyclopedia of Rhetoric (741-745). New York, NY: Oxford University Press.Hemington, G. (2019, 9 April). A guide for (the) perplexed philosophers: Jesse Singal and the rationalist subculture. Irrationally Speaking. https://irrationallyspeaking.home.blog/2019/04/09/a-guide-for-the-perplexed-philosophers-jesse-singal-and-the-rationalist-subculture/Mack, P. (2016). Ramus and Ramism: rhetoric and dialectic. In Ramus, Pedagogy and the Liberal Arts (pp. 23-40). Routledge.

U Of Richmond Prof Jack Singal On UFO Report 06 - 28 - 21 by The Watchdog

The 68th episode of dToks features Sanjay Singal, COO of ITC

Today, I am joined by Dr. Arbinder Singal. He is the Co-founder and CEO of Fitterfly. Fitterfly is a health tech start-up operating in the space of Digital Therapeutics (DTx), a subset of Digital health. DTx is the convergence of digital technologies with health, lifestyle, coaches, and assisted devices to enhance the efficiency of healthcare delivery and improve outcomes for patients with chronic diseases. We speak about The importance of convergence of digital technologies with health and lifestyle.Check out Socially DesiFollow us on Instagram

In today's conversation, Gaurav Singal, who is the outgoing Chief Data Officer of Foundation Medicine, discusses the advent of molecularly-driven oncology in changing the paradigm of cancer diagnosis and treatment through precision medicine, the importance of using observational data, and the unpredictable nature of one's career that may yield a convergence of what were once disparate fields. Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary --- Support this podcast: https://anchor.fm/the-data-pulse/support

Jesse Singal, a New York-based writer, talks to Quillette's Jonathan Kay about the reaction to his controversial cover story for The Atlantic about transgender adolescents. Among other things, Singal interviewed a number of adults who have "detransitioned"—had a change of heart about switching genders after undergoing irreversible medical procedures. This provoked accusations of "transphobia" from trans activists, who argued that highlighting these cases would make parents and mental health professionals needlessly sceptical when reacting to children's self-diagnosis of gender dysphoria and make it more difficult for those children to get medical treatment.